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Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are encoded by four
genes (HCN1–4) and, through activation by cyclic AMP (cAMP), represent a point of
convergence for several psychosis risk genes. On the basis of positive preliminary data,
we sought to test whether genetic variation in HCN1–4 conferred risk of depression or cog-
nitive impairment in the Generation Scotland: Scottish Family Health Study. HCN1, HCN2,
HCN3, and HCN4 were genotyped for 43 haplotype-tagging SNPs and tested for asso-
ciation with DSM-IV depression, neuroticism, and a battery of cognitive tests assessing
cognitive ability, memory, verbal ﬂuency, and psychomotor performance. No association
was found between any HCN channel gene SNP and risk of depression, neuroticism, or on
any cognitive measure. The current study does not support a genetic role for HCN chan-
nels in conferring risk of depression or cognitive impairment in individuals from the Scottish
population.
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INTRODUCTION
Mood disorders and schizophrenia are common and disabling
conditions in which stressful life events and genetic risk factors are
known to contribute to the risk of illness (Murray and Lopez, 1997;
Sullivan et al., 2000). Impairment in cognitive function is associ-
ated with a variety of psychiatric disorders (Aleman et al., 1999;
Austin et al., 2001; Bearden et al., 2001; McIntosh et al., 2005).
Cognitive functions such as memory and planning appear to be
particularly important and have been shown to contribute signif-
icantly to disability, diminished quality of life, and the ability to
live independently (Alexopoulos et al., 2000; Dimitris et al., 2000).
However, unlike positive psychotic symptoms and pathological
mood states, these deﬁcits are still largely irremediable (Galletly,
2009; Goldberg and Chengappa, 2009).
The relationship of cognitive performance to stress is described
by the inverted U-shaped Yerkes–Dodson curve (Yerkes and Dod-
son, 1908). This relationship is partially mediated by release of
dopamine and/or noradrenaline, with downstream effects on
cyclic AMP (cAMP) signaling through Gs protein coupled recep-
tors (Wang et al., 2007; Robbins and Arnsten, 2009). Although
cAMP has many downstream effects, the time course of impaired
executive function is perhaps most consistent with the rapid
downstreameffects of cAMPonhyperpolarization-activated cyclic
nucleotide-gated (HCN) channels (Wang et al., 2007). Indeed,
HCN channels have been shown to have a signiﬁcant role in the
development of stress-induced cognitive impairment (Arnsten,
2007). Stimulation by cAMP facilitates rapid opening of these
receptors and an inwardly hyperpolarizing current referred to as
Ih (Wahl-Schott and Biel, 2009). These currents, in turn, cause
perturbations in neuronal signaling through reduced dendritic
summation of incoming currents.
Several lines of evidence in animal studies are in support of the
hypothesis that HCN channels may have a role in mediating the
deleterious effects of stress. This work includes research demon-
strating the possible efﬁcacy of the compound guanfacine in
improving attention and working memory, a drug which inhibits
one of the pathways activating HCN channels (Wang et al., 2007).
Genetic variants DISC1, PDE4B, DGKH, and RGS4, each of
which affect cAMP signaling, have risk modifying effects in mood
disorders and schizophrenia (Thomson et al., 2005; Talkowski
et al., 2006; Baum et al., 2007; Pickard et al., 2007). None to
date show clear diagnostic speciﬁcity, although there is some
evidence that they are associated with impairments in cogni-
tion common to several psychiatric disorders (Porteous et al.,
2006). Since cAMP activates HCN channels, variants in their
genes would therefore also be good candidates for genetic risk
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factors to a spectrum of psychiatric conditions. Indeed, we
have previously reported preliminary evidence in support of an
association between rs12905211 in HCN4 and risk of a broad
psychiatric phenotype consisting of depression, anxiety disorders,
and obsessive-compulsive disorder (Kelmendi et al., 2011). The
original study (N = 285 cases, 384 controls) and the strength
of the association were modest in size (OR = 1.35–1.5) but
warranted further investigation. Here, we seek further evidence
for an association of HCN channel genes and common vari-
ants with depression, neuroticism, and cognitive function in a
large independent cohort. In addition, we used neuroticism as
a proxy for stress sensitivity and examined its interaction with
HCN1–4, whose effects on risk of MDD may be mediated through
stress-induced cognitive impairment.
MATERIALS AND METHODS
The Generation Scotland: the Scottish Family Health Study
(GS:SFHS) is amulti-institution study of the genetic contributions
tohealth anddisease in the Scottish population (Smith et al., 2006).
The study identiﬁed potential participants from general practices
throughout Scotland, along with as many ﬁrst- and second-degree
relatives as could be recruited; volunteers and their relatives were
also recruited. Participants completed a pre-assessment question-
naire, attended a clinic where physical measurements were made
and undertook detailed measures of neuropsychological function.
A sample of blood or saliva was taken from which genomic DNA
was extracted.
The neuropsychological test battery used included the Mill
Hill Vocabulary Test (Raven et al., 1977; general cognitive ability),
the Logical Memory Test (Wechsler, 1998; mnemonic func-
tion), the Digit Symbol Substitution test from the WAIS IIIR
(Wechsler, 1998; psychomotor performance), and an estimate
of verbal ﬂuency (Lezak, 1995; executive function) which mea-
sured the numbers of words beginning with the letters C, F, or L
generated verbally within 1 min. Individuals also completed the
NEO ﬁve-factor inventory (NEO-FFI; Costa and McCrae, 1989) in
order to provide measures of neuroticism and extraversion, traits
previously linked to susceptibility to depression (Kendler et al.,
1993, 2006).
A total of 23,960 individuals have provided informed con-
sent of which 21,476 underwent clinical and cognitive assessments
and provided DNA. Participants were screened for emotional and
psychiatric disorder using the screening module from Structured
Clinical Interview for DSM-IV (SCID, axis I) with a researcher
trained in its use. An afﬁrmative answer to at least one screen-
ing question [Question (1) “Have you ever seen anybody for
emotional or psychiatric problems?” Question (2) “Was there
ever a time when you, or someone else, thought you should
see someone because of the way you were feeling or acting?”]
was interpreted as a positive screen. Those who screened positive
were invited to continue the interview, which focused on major
depression and bipolar disorder. Lifetime diagnoses were made
according to DSM-IV criteria and information on the lifetime
number of depressive episodes was also provided. Researchers
received ﬁeld training and reliability assessments involving an
independent, blind rating of the interviews by a trained psychi-
atrist (Donald J. MacIntyre). Inter-rater reliability for presence or
absence of a lifetime diagnosis of major depressive disorder was
determined: in the sample (N = 58) Kappa = 0.86 (p < 0.001),
95% CI (0.7, 1.0).
A total of 1501 conﬁrmed cases of DSM-IV major depres-
sive disorder were identiﬁed in the full GS:SFHS cohort, using
the SCID. Screened negative controls (N = 4499) were matched
to cases for age and sex as far as possible. The sample size
had >80% power to detect an association between the HCN4
SNP rs12905211, previously reported to show an association
with a broad psychiatric phenotype, and MDD (calculation per-
formed using online software: http://pngu.mgh.harvard.edu/∼
purcell/gpc/).
Genotyping of DNA was performed on the Applied Biosystems
OmniExpress Array using TaqMan SNP genotyping assays. SNP
assays were selected for HCN1 (5p12), HCN2 (19p13.3), HCN3
(1q22), and HCN4 (15q24.1) using Tagger with HaploView soft-
ware using a pairwise allele tagging threshold of r2 = 0.8 and a
minimum minor allele frequency (MAF) of 1%. Details of the
genomic regions spanned by each SNP set are provided in Table 2
and included the promoter and 5′ regions of each gene 2 Kb
upstream from the transcription start site and 2 Kb downstream
from the 3′ UTR.
STATISTICAL ANALYSIS
All clinical, cognitive, and genotyping data was imported into
the R software package for analysis of demographic and histori-
cal information. The mean age of controls, individuals with an
episode of MDD, and those with recurrent MDD were then com-
pared using univariate ANOVA. These variables differed between
the three groups, therefore subsequent analyses of the cognition,
neuroticism, and extraversion are conducted controlling for these
potential confounds. Post hoc tests were conducted using Tukey’s
method. Depression, neuroticism, extraversion, and all cognitive
variables were then exported to the PLINK (Purcell et al., 2007)
genetic software analysis package (version 1.07, http://pngu.mgh.
harvard.edu/purcell/plink/) for further analysis.
Forty-three SNPs out of 44 SNPs genotyped passed quality
control procedures (>95% genotype success rate, no signiﬁcant
deviation from Hardy–Weinberg equilibrium, PHWE > 0.005 in
control participants). Genetic association of HCN1–4 SNPs with
depression was tested by conducting a logistic regression analysis,
adjusted for age and sex, followed by a likelihood ratio-based test
of association for each individual SNP. We analyzed the associa-
tion with all MDD (single episode and recurrent MDD) initially
followed by an analysis of recurrent MDD only on the basis that
recurrent MDD may represent a more heritable form of the disor-
der (Levinson, 2006). Genetic association with continuous traits
was conducted using a linear regression model. All analyses were
adjusted for age, any diagnosis of MDD, and sex. Sixty-ﬁve indi-
viduals of non-European ancestry were excluded from the genetic
analyses on the basis of self reported ethnicity and family his-
tory. Finally, to examine whether there was an association between
each SNP and each measure based on a trait liability to stress, we
repeated the above linear models examining HCN1–4 SNP effects
on cognition including the SNP × neuroticism interaction term
(as well as the SNP and neuroticism main effects), whilst retaining
“any episode of depression,” age and sex as covariates in the model.
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All of the analyses with quantitative traits were then repeated
without MDD as a covariate, with no changes in any of the
conclusions. We then reported any associations that survived a
false discovery rate correction (Benjamini and Hochberg, 2000) of
p < 0.05 as signiﬁcant, although nominally signiﬁcant results are
reported in the tables.
RESULTS
At the start of the study 6000 individuals provided useable clinical
and cognitive data of which 4499 had no psychiatric diagnosis and
1501 met criteria for DSM-IV major depressive disorder (N = 733
recurrent, N = 768 with a single episode). The rate of depression
in the GS:SFHS cohort as a whole reﬂects that in the Scottish
population, but since this study was limited to 6000 samples, we
maximized statistical power by over sampling individuals with
MDD initially before ﬁlling the remaining spaces with control
participants. Demographic and historical details of the diagnostic
groups are shown in Table 1 and details of the genotyping in
Table 2.
There were signiﬁcant differences in age and sex between the
groups, with both depressed groups being younger and more
frequently female than controls. Unadjusted mean values of neu-
roticism, extraversion, and the cognitive variables are presented in
Table 1. After adjustment for age and sex, there were signiﬁcant
differences in Mill Hill Vocabulary (a higher mean vocabulary
score was found in individuals with recurrent depression than in
controls), Digit symbol coding (better performance in controls
than in either depressed group), neuroticism scores (recurrent
MDD > single episode MDD > controls), and extraversion score
(recurrent MDD< single episode MDD< controls).
There was no evidence of an association between any SNP
in HCN1–4 and major depression (recurrent and singe episodes
combined) in the GS:SFHS sample (Table 3) after adjustment
Table 1 | Demographic and cognitive details of study participants.
Control group MDD episode Recurrent
(N = 4499) (N = 768) MDD
(N = 733)
Age, mean (SD) 52.4 (13.7) 45.8 (13.3) 47.1 (12.1)
Male sex, N (%) 1890 (42.0) 260 (33.9) 275 (37.5)
Mill Hill Vocabulary, 30.7 (4.8) 30.1 (4.9) 30.5 (4.9)
mean (SD)
Digit symbol coding, 70.2 (17.3) 72.4 (16.3) 70.2 (16.3)
mean (SD)
Logical memory score, 15.8 (3.9) 16.2 (3.8) 15.8 (3.9)
mean (SD)
Logical memory (delayed), 14.6 (4.32) 15.1 (4.2) 14.7 (4.2)
mean (SD)
Verbal ﬂuency, mean (SD) 40.0 (11.8) 40.3 (12.0) 40.1 (11.8)
Neuroticism, mean (SD) 3.1 (2.8) 5.5 (3.3) 7.3 (3.1)
Extraversion, mean (SD) 7.8 (3.4) 7.7 (3.5) 6.7 (3.9)
for age and sex (data before adjustment available on request).
Similarly, there were no signiﬁcant associations between SNPs in
HCN1–4 and neuroticism, extraversion or any domain of cog-
nition. The smallest nominally signiﬁcant associations between
SNPs in HCN1–4 and individual traits are shown in Table 4.
We then repeated the analyses examining HCN1–4 SNP effects
on neuroticism, extraversion, and cognition in the absence of
MDD as a covariate, and all of the associations remained non-
signiﬁcant. Finally, we found that there was no statistically
signiﬁcant interaction between SNPs in HCN1–4 and neuroti-
cism for the dependent variables considered in the current
study.
CONCLUSION
In the current study, no evidence could be found to support an
association between genetic variants in HCN1–4 and liability to
depression, including measures of neuroticism or extraversion.
Furthermore, no evidence was found to support an association
between these four HCN channel genes and cognitive impair-
ment, either as main effects or as interacting risk factors with
neuroticism.
Whilst a role for HCN channels in mediating these effects can-
not be excluded, common variants in HCN1–4 appear to have no
effect on risk of depression or on cognitive performance in Cau-
casian individuals of presumed Scottish descent. The current study
can also not exclude the possibility that rare functional variants in
HCN1–4 may affect risk of depression or cognition.
The results of the present investigation differ from our previ-
ous study where we reported a signiﬁcant association between
rs12905211 in HCN4 and a phenotype comprised of unipolar
and bipolar depression and/or anxiety disorder. The two stud-
ies differed in a number of important ways. Notably, the present
study utilized a population sample whereas we previously studied
a particularly ill sample of patients recruited from a tertiary care
setting. The present sample was also composed almost exclusively
of Caucasian non-Hispanic British participants whereas the previ-
ous sample was composed of Hispanic American individuals with
mixed backgrounds. Finally, the present study was much larger
than the previous sample of less than 700 participants. However,
the ﬁnding of a signiﬁcant association in one study and a subse-
quent failure to replicate in another has frequently been referred to
in the literature as “winner’s curse”and underlines the importance
of independent replication.
Certain limitations of the current study should be taken into
accountwhen interpreting these results. Firstly, the psychiatric and
psychological assessments within GS:SFHS were not conducted
by a trained psychiatrist or post-doctoral psychologist. All assess-
ments were however conducted by a research assistant trained and
validated in the use of the cognitive instruments or the SCID after
a period of training with an experienced psychiatrist (Donald J.
MacIntyre) or psychologist (Ian J. Deary). The cognitive and per-
sonality assessments were also conducted blind to genotype and
with ongoing quality assurance, reliability assessments and after
extensive ﬁeld-testing. SCID-based interviews took into account
both current and lifetime histories of mood disorder. The reliabil-
ity of the SCID ratings compared with that of a blind, independent
psychiatrist were excellent (ICC = 0.86, 95% CI 0.7–1.0) and are
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Table 2 | HCN1–4 haplotype-tagging SNPs.
CHR GENE Position SNP Alleles* GENO MAF PHWE (Control)
1 HCN3 155255367 rs12239421 AC 0/8/5696 <0.01 1.00
1 HCN3 155260382 rs1052176 TG 419/2196/3140 0.26 0.41
5 HCN1 45249603 rs10512876 CT 9/444/5402 0.04 0.84
5 HCN1 45265767 rs13180087 CT 80/1108/4287 0.12 0.31
5 HCN1 45266588 rs4866929 GA 1266/2865/1694 0.46 0.41
5 HCN1 45282807 rs16902083 CA 207/1792/3765 0.19 0.69
5 HCN1 45285751 rs16902086 GA 666/2622/2547 0.34 0.71
5 HCN1 45286096 rs16902088 CT 0/110/5734 0.01 1.00
5 HCN1 45286357 rs17343612 CT 20/563/5272 0.05 0.22
5 HCN1 45307592 rs1604320 AG 12/511/5345 0.05 1.00
5 HCN1 45307925 rs12655983 GT 117/1339/4371 0.14 0.23
5 HCN1 45326772 rs1501361 GT 197/1700/3840 0.18 0.64
5 HCN1 45419587 rs13163424 TC 15/502/5013 0.05 0.16
5 HCN1 45448579 rs6875925 GC 13/614/5221 0.05 0.55
5 HCN1 45491938 rs1483307 GA 1188/2711/1753 0.45 0.03
5 HCN1 45509574 rs17293295 AG 350/2130/3371 0.24 0.09
5 HCN1 45530621 rs12374423 AC 5/326/5523 0.03 1.00
5 HCN1 45614224 rs17344896 CT 66/1071/4727 0.10 0.04
5 HCN1 45622495 rs6893773 AC 1073/2865/1919 0.43 0.32
5 HCN1 45651561 rs4339358 AG 432/2223/2943 0.28 0.07
5 HCN1 45666145 rs17345592 GA 17/604/5234 0.05 1.00
15 HCN4 73612376 rs524457 AG 15/654/5195 0.06 0.34
15 HCN4 73612832 rs549377 CT 37/700/5034 0.07 0.18
15 HCN4 73625894 rs488156 GA 1373/2870/1587 0.48 0.38
15 HCN4 73628085 rs2623998 TC 343/2092/3416 0.24 0.36
15 HCN4 73628167 rs12905211 TC 1135/2795/1848 0.44 0.56
15 HCN4 73628213 rs8030574 CA 309/2003/3424 0.23 0.97
15 HCN4 73628713 rs2623997 TC 1354/2869/1566 0.48 0.74
15 HCN4 73631829 rs3784807 AG 1370/2907/1586 0.48 0.30
15 HCN4 73632868 rs512943 TC 47/901/4886 0.09 0.07
15 HCN4 73644395 rs568760 TC 3/200/5660 0.02 0.13
15 HCN4 73649592 rs477377 TC 26/736/5047 0.07 0.39
15 HCN4 73650823 rs3826046 AG 69/1063/4711 0.10 0.25
15 HCN4 73652173 rs7164883 GA 133/1506/4227 0.15 0.86
15 HCN4 73653008 rs12440104 AG 996/2758/2053 0.41 0.30
15 HCN4 73653484 rs2680344 GA 274/2024/3522 0.22 0.79
15 HCN4 73671516 rs3940418 CG 21/721/4800 0.07 0.63
19 HCN2 583267 rs13676 AG 39/666/5030 0.06 0.01
19 HCN2 583459 rs6758 AG 26/571/5192 0.05 0.05
19 HCN2 593017 rs12977194 GA 270/2029/3528 0.22 0.22
19 HCN2 605984 rs7255568 AG 1110/2777/1919 0.43 0.14
19 HCN2 607318 rs34167478 CT 0/56/5689 <0.01 1.00
19 HCN2 607983 rs3752158 CG 13/639/5021 0.06 0.12
*First letter denotes minor allele; MAF, minor allele frequency.
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Table 3 | Association of HCN1–4 with depression.
All MDD Recurrent MDD
CHR GENE SNP BP A1 OR t p-value OR t p-value
1 HCN3 rs12239421 155255367 A 0.00 0.00 1.00 0.00 0.00 1.00
1 HCN3 rs1052176 155260382 T 0.93 −1.39 0.16 1.01 0.10 0.92
5 HCN1 rs10512876 45249603 C 1.00 0.03 0.98 0.90 −0.72 0.47
5 HCN1 rs13180087 45265767 C 1.07 0.97 0.33 0.92 −0.84 0.40
5 HCN1 rs4866929 45266588 G 0.99 −0.23 0.82 1.06 1.00 0.32
5 HCN1 rs16902083 45282807 C 1.02 0.40 0.69 0.99 −0.07 0.94
5 HCN1 rs16902086 45285751 G 1.04 0.87 0.38 0.95 −0.80 0.42
5 HCN1 rs16902088 45286096 C 0.91 −0.43 0.67 0.81 −0.68 0.50
5 HCN1 rs17343612 45286357 C 0.96 −0.41 0.68 0.88 −0.93 0.35
5 HCN1 rs1604320 45307592 A 0.91 −0.88 0.38 1.03 0.23 0.82
5 HCN1 rs12655983 45307925 G 1.07 1.04 0.30 0.94 −0.67 0.50
5 HCN1 rs1501361 45326772 G 1.07 1.20 0.23 0.92 −1.12 0.26
5 HCN1 rs13163424 45419587 T 1.13 1.24 0.22 0.93 −0.54 0.59
5 HCN1 rs6875925 45448579 G 1.06 0.62 0.53 0.89 −0.84 0.40
5 HCN1 rs1483307 45491938 G 0.98 −0.36 0.72 1.05 0.80 0.42
5 HCN1 rs17293295 45509574 A 1.10 1.98 0.05 1.05 0.76 0.45
5 HCN1 rs12374423 45530621 A 1.13 0.99 0.32 0.85 −0.89 0.37
5 HCN1 rs17344896 45614224 C 0.96 −0.58 0.56 1.10 1.07 0.28
5 HCN1 rs6893773 45622495 A 1.07 1.57 0.12 1.01 0.18 0.86
5 HCN1 rs4339358 45651561 A 1.10 1.94 0.05 1.01 0.08 0.93
5 HCN1 rs17345592 45666145 G 0.87 −1.46 0.14 0.79 −1.76 0.08
15 HCN4 rs524457 73612376 A 1.03 0.30 0.76 1.16 1.29 0.20
15 HCN4 rs549377 73612832 C 0.98 −0.27 0.79 0.99 −0.09 0.93
15 HCN4 rs488156 73625894 G 1.00 0.04 0.97 0.96 −0.65 0.52
15 HCN4 rs2623998 73628085 T 0.95 −1.09 0.27 0.91 −1.37 0.17
15 HCN4 rs12905211 73628167 T 1.01 0.12 0.91 0.96 −0.66 0.51
15 HCN4 rs8030574 73628213 C 0.96 −0.85 0.39 0.95 −0.70 0.48
15 HCN4 rs2623997 73628713 T 0.96 −0.95 0.34 0.94 −1.11 0.27
15 HCN4 rs3784807 73631829 A 0.99 −0.23 0.82 0.99 −0.22 0.82
15 HCN4 rs512943 73632868 T 0.95 −0.69 0.49 0.91 −0.88 0.38
15 HCN4 rs568760 73644395 T 1.12 0.69 0.49 1.10 0.45 0.65
15 HCN4 rs477377 73649592 T 1.06 0.69 0.49 1.01 0.05 0.96
15 HCN4 rs3826046 73650823 A 1.01 0.07 0.95 0.97 −0.35 0.73
15 HCN4 rs7164883 73652173 G 0.97 −0.46 0.64 0.99 −0.13 0.90
15 HCN4 rs12440104 73653008 A 1.02 0.35 0.73 1.06 0.99 0.32
15 HCN4 rs2680344 73653484 G 1.01 0.12 0.91 1.00 0.03 0.97
15 HCN4 rs3940418 73671516 C 0.96 −0.42 0.68 0.93 −0.60 0.55
19 HCN2 rs13676 583267 A 0.98 −0.28 0.78 1.08 0.69 0.49
19 HCN2 rs6758 583459 A 0.95 −0.52 0.60 0.84 −1.27 0.20
19 HCN2 rs12977194 593017 G 1.00 0.01 1.00 1.07 0.92 0.36
19 HCN2 rs7255568 605984 A 1.00 −0.02 0.98 0.99 −0.11 0.91
19 HCN2 rs34167478 607318 C 1.31 0.90 0.37 1.14 0.32 0.75
19 HCN2 rs3752158 607983 C 1.12 1.26 0.21 1.13 1.01 0.31
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Table 4 | Association of HCN1–4 with cognition, neuroticism or
extraversion where unadjusted p-value <0.05.
GENE CHR SNP BP A1 BETA STAT p
Digit symbol coding
HCN4 15 rs12905211 73628167 T −0.64 −2.29 0.02
HCN1 5 rs17343612 45286357 C −1.26 −2.01 0.04
Neuroticism
HCN1 5 rs1483307 45491938 G 0.13 2.40 0.02
HCN1 5 rs6893773 45622495 A −0.12 −2.18 0.03
HCN1 5 rs4339358 45651561 A −0.13 −2.08 0.04
Logical memory
HCN1 5 rs17343612 45286357 C −0.42 −2.64 0.01
HCN1 5 rs1483307 45491938 G −0.17 −2.41 0.02
HCN1 5 rs4866929 45266588 G −0.15 −2.16 0.03
Logical memory delayed
HCN1 5 rs12374423 45530621 A −0.57 −2.43 0.02
HCN1 5 rs17343612 45286357 C −0.38 −2.20 0.03
HCN2 19 rs3752158 607983 C −0.35 −2.08 0.04
HCN1 5 rs1483307 45491938 G −0.16 −1.98 0.05
Mill Hill Vocabulary
HCN4 15 rs3826046 73650823 A 0.40 2.86 0.004
HCN4 15 rs12905211 73628167 T −0.21 −2.49 0.01
HCN1 5 rs16902083 45282807 C −0.25 −2.24 0.02
unlikely to have obscured any positive ﬁndings. A further consid-
eration in interpreting the current ﬁndings is the fact that four
HCN1–4 SNP assays initially failed manufacture, three of which
were in the HCN2 gene. Replacements were subsequently found
in HCN1 although two further proxy SNPs failed manufacture in
HCN2 after a second account and at least eight SNPs in HapMap
2 (release 2) could not be captured using the current assays. It is
therefore important to note that a proportion of common genetic
variation in HCN2 was not captured in the current study.
It is also possible that the current study, although it is the largest
by far to examine this issue to date, was still nonetheless of insuf-
ﬁcient size to detect an important genetic effect of HCN1–4. It is
therefore possible that these may emerge as signiﬁcant risk fac-
tors for depression or cognitive impairment in larger samples,
although the sample size of 6000 is exceptionally large for a single
case–control association study.
It is also important to note that, whereas preclinical research
has employed measures of attention and working memory in
elucidating a role for HCN channels in cognition, we measured
verbal ﬂuency. Although such measures are very useful clini-
cally it is possible that the role of HCN channels is speciﬁc to
certain sub-domains of executive functioning, and future stud-
ies should therefore include measures of attention and working
memory.
In the current study we found no evidence to support a role
for HCN channel genes in the etiology of depression. However,
the evidence from basic neuroscience still supports a role for these
channels in conveying the effects of stress-related cognitive impair-
ment. Future studies might seek to address their functional role in
larger samples, in individuals with rare variants, or using in vitro
methods.
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